October 14, 2022 — Heart Initiative, the sponsor of the STRONG-HF (Safety, Tolerability and efficacy of Rapid ...
October 13, 2022 — Tenax Therapeutics, Inc., a specialty pharmaceutical company focused on identifying, developing, and ...
October 13, 2022 — Cardio Diagnostics, Inc. , a pioneering precision cardiovascular testing company, announced that the ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
October 13, 2022 — Zach Williams thought he’d become a cancer researcher when he joined Virginia Tech’s Translational ...
At TCT 2022, Deepak Bhatt, MD, MPh, Executive Director of Interventional Cardiovascular Programs, Brigham and Women's ...
October 12, 2022 — Following the recent European Society of Cardiology (ESC) Congress in Barcelona, Spain last month ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
October 12, 2022 — Cleveland Clinic researchers have identified a common diabetes medication, metformin, as a possible ...
October 12, 2022 — HeartBeam, Inc., a cardiac technology company that has developed the first and only 3D-vector ECG ...
Change Healthcare’s cloud-native archiving, viewing, and image-sharing solutions can help improve efficiencies in ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
October 11, 2022 — The preliminary results of the first-in-human (FIH) trials for the innovative ELANA Heart Bypass ...
October 11, 2022 — Researchers from the University of Minnesota Medical School found that patients with certain features ...
October 11, 2022 — Efemoral Medical, developer of advanced interventional bioresorbable therapies, announced that it has ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
October 7, 2022 — A new research grant will enable University of Cincinnati researchers to learn more about how ...
October 7, 2022 — Ultromics, a digital health technology company pioneering the development of transformative heart ...
October 7, 2022 — ChromaDex Corp. announced promising findings from a clinical study, as reported in the peer-reviewed ...